English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, June 16, 2022
Legend Capital Increases Carbon Neutrality Investments: Portfolio Company Talent New Energy Completes A++ Financing Round with Several Hundred Million RMB
Wednesday, June 15, 2022
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
Thursday, June 9, 2022
Legend Capital Portfolio: Japan's No.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange
Friday, May 27, 2022
Legend Capital's Portfolio Company Feima Robotics Assists China's 38th Antarctic Expedition with a Series of Civilian UAV Products
Wednesday, April 27, 2022
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Tuesday, April 26, 2022
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022
Sunday, April 24, 2022
君联资本联合创建企业朗信生物遗传性视网膜变性基因治疗产品在中国获批临床
君聯資本聯合創建企業朗信生物遺傳性視網膜變性基因治療產品在中國獲批臨床
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Thursday, April 7, 2022
君联资本所投创新型疫苗领军企业瑞科生物在港交所成功上市

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575